Conditions: Heart Failure
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 18
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the effects of CLP, with and without spironolactone, on serum, urine, and fecal contents in heart failure patients with chronic kidney disease.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: CLP intervention 2: Spironolactone
Intervention descriptions: intervention 1: Oral administration intervention 2: oral administration

Protocol document: